Chromogranin A: osmotically active fragments and their susceptibility to proteolysis during lysis of the bovine chromaffin granules.
Osmotically active fragments of chromogranin A (Chr A) were studied in lysates from bovine chromaffin granules (CG) disrupted in the presence or absence of inhibitors of endogenous proteolytic activities. The effects of various methods of lysis were examined by micro-osmometry, PAGE-SDS electrophoretic techniques and immunoblots with polyclonal anti-Chr A sera. Osmotically active 'small' Chr A fragments (below 30 kDa) were conspicuous in lysates containing cocktails of leupeptin, pepstatin A, pHMB, PMSF and aprotinin. The osmotically inactive native Chr A in the 68-100 kDa range and the osmotically active fragments below 47 kDa were degraded in lysates at neutral or acid pH in the absence of inhibitors. However, degradation of the native Chr A and intermediates below 47 kDa could be prevented by extraction directly from intact CG, notably in cold or boiling distilled water. On the other hand, the main product after large-scale extraction of CG in 1 M acetic acid (pH 1.9, 100 degrees C) was a novel, osmotically active fragment (22 kDa), immunostaining only for the N-terminal sequence (Chr A1-40). The heat-stable fraction (Mr,n 23 kDa) exhibited concentration-independent colloid osmotic pressures even in the absence of phosphate, a property which may distinguish this N-terminal-containing fragment from the larger intermediates, probably containing the pancreastatin sequence, and other regions at the C-terminal side of the prohormone molecule. The functional roles of these osmotically active intermediates in the processing of Chr A are not yet known.
Helle
K B
KB
Department of Physiology, PKI, University of Bergen, Norway.
Reed
R K
RK
Ehrhart
M
M
Aunis
D
D
Hogue Angeletti
R
R
D000143:Acids / Q000494:pharmacology; D000311:Adrenal Glands / Q000166:cytology / Q000187:drug effects; D000818:Animals; D002417:Cattle; D002837:Chromaffin Granules / Q000032:analysis* / Q000187:drug effects / Q000378:metabolism; D002838:Chromaffin System / Q000032:analysis*; D053379:Chromogranin A; D002864:Chromogranins / Q000032:analysis* / Q000276:immunology / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D015151:Immunoblotting; D009419:Nerve Tissue Proteins / Q000032:analysis*; D009994:Osmolar Concentration; D010446:Peptide Fragments / Q000032:analysis / Q000276:immunology / Q000378:metabolism; D010447:Peptide Hydrolases / Q000494:pharmacology*
D000143:Acids; D053379:Chromogranin A; D002864:Chromogranins; D009419:Nerve Tissue Proteins; D010446:Peptide Fragments; D010447:Peptide Hydrolases